Net Cash Provided by (Used in) Operating Activities |
-44.8K |
USD |
-37.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
433K |
USD |
+982% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-388K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
500M |
shares |
+44.3% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
105 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
51.2K |
USD |
-47.6% |
Q2 2024 |
Q2 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.23M |
USD |
+30.1% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
51.2K |
USD |
-47.6% |
Q2 2024 |
Q2 2024 |
Current Income Tax Expense (Benefit) |
199K |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
|
Q4 2022 |
Q2 2024 |
Additional Paid in Capital |
61.7M |
USD |
|
Q1 2022 |
Q1 2022 |
Share-based Payment Arrangement, Expense |
-24K |
USD |
-169% |
Q1 2024 |
Q1 2024 |
Interest Expense |
8.2K |
USD |
|
Q2 2022 |
FY 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |